Today

Agents

Chat

Arena

Discover

More

App

Neurogene Q2 Operating Expenses USD 36.67 Million - NGNE News | Rallies

Neurogene Q2 Operating Expenses USD 36.67 Million

NGNE•2026-08-11

Q2 results

Aug. 11 (Reuters) - Neurogene Q2 net income was USD -34.488 million.

Q2 operating income was USD -36.67 million.

Related News

Coya Therapeutics posts investor presentation on Treg-directed combination therapy for neurodegenerative diseases

COYA•2026-08-11

Baiya targets further BNB purchases under Binance Plan capital allocation framework

BIYA•2026-08-11

UK MHRA expands Rhythm’s IMCIVREE authorization to treat acquired hypothalamic obesity

RYTM•2026-08-11

Mereo BioPharma Q2 FY26 net loss narrows to $7 million; R&D expenses drop to $1.81 million

MREO•2026-08-11

CME Group expands 24/7 trading to 100-ounce silver futures from Sept. 11

CME•2026-08-11